Related by context. All words. (Click for frequent words.) 84 preclinical studies 73 IND enabling 72 preclinical toxicology 72 clinical trials 71 Preclinical 70 preclinical efficacy 68 Phase III clinical 68 JAK inhibitor 67 Phase III clinical trials 67 GLP toxicology studies 67 Phase Ib 67 clinical trial 66 clinical 66 Phase IIa 66 Phase IIa clinical trials 66 oral prodrug 66 Phase Ib clinical 66 small molecule 66 AVN# [001] 66 TKM ApoB 66 Phase 2b clinical 66 preclinical models 65 Phase IIb 65 ZFP Therapeutic 65 nonclinical studies 65 Phase IIa clinical 65 Phase III trials 65 MEK inhibitor 65 Factor VIIa 65 Phase 2a trial 64 PSN# [002] 64 DXL# 64 Phase IIb clinical 64 Panzem 64 Phase 2a clinical 64 Phase Ib study 64 phase IIa clinical 64 Neo Kidney Augment ™ 64 Phase 2a 64 ANAVEX #-# [003] 64 Phase IIa trial 64 therapeutic antibody 64 HspE7 63 vivo 63 Phase 2b study 63 OXi# 63 phase IIb clinical 63 vivo efficacy 63 PDE4 inhibitor 63 Phase IIb clinical trials 63 CD# CEA 63 R#/MEM # 63 MLN# 63 phase IIa 63 GAP #B# 63 histone deacetylase HDAC inhibitor 63 Prodarsan ® 63 biomarker discovery 63 OvaRex R 63 APD# 63 Tolerx 63 PLK1 SNALP 63 phase IIb 63 seliciclib CYC# 63 ALN TTR# 63 pharmacokinetic 63 Homspera 63 PXD# 63 IND submission 63 IDX# 63 INCB# [001] 63 cannabinor 62 epothilone 62 Archexin 62 VEGF Trap 62 NGX# 62 Phase IIb trials 62 Phase IIa trials 62 PRT# 62 Guanilib 62 HCV polymerase inhibitor 62 midstage trials 62 Phase 2a clinical trials 62 Trofex 62 BCX# 62 ISIS # 62 Phase 1b 62 iroxanadine 62 Phase III 62 PEG SN# 62 teduglutide 62 CRLX# 62 nicotinic alpha 7 62 Azedra 62 ASONEP 62 therapeutics 62 TOCOSOL Paclitaxel 62 isoform selective 62 Onconase 62 ALN PCS 62 investigational drug 62 Fx #A 62 MOR# 62 vivo preclinical 62 Charlesson 62 Neo Kidney Augment 62 KNS # 61 ENMD # 61 OncoVEX GM CSF 61 Phase Ib clinical trials 61 RDEA# 61 Nanobody ® 61 JAK2 inhibitor 61 AQ4N 61 Triolex 61 DOS# 61 RNAi therapeutic 61 targeted radiotherapeutic 61 BiTE antibody 61 Phase 2b clinical trials 61 CEQ# 61 preclinical compounds 61 HGS ETR1 61 PRX # 61 obatoclax 61 Phase 2b 61 Onalta 61 Preclinical studies 61 RGB # 61 orally bioavailable 61 GRN#L 61 HQK 61 novel peptides 61 next generation URAT1 61 selective androgen receptor modulator 61 monoclonal antibodies 61 Azixa 61 Panzem R 61 GPR# agonist 61 ganetespib 61 Protexia ® 61 Sym# 61 synthetic retinoid 61 rxRNA 61 TRIOLEX 61 midstage clinical 61 monoclonal antibody 61 Phase 1a clinical 61 Phase 1b trial 61 XmAb ® 61 CCR9 antagonist 61 KineMed 61 investigational humanized monoclonal antibody 61 Aerosurf 61 Intellikine 61 antisense drug 61 CORT # 61 JAK1 61 therapeutic monoclonal antibody 61 Exherin TM 61 NEUMUNE 60 Tarvacin TM 60 atacicept 60 5 HT6 antagonist 60 therapeutic monoclonal antibodies 60 HCV nucleotide polymerase inhibitor 60 pradefovir 60 MEK inhibitors 60 nanoviricides 60 MGCD# [001] 60 Symadex 60 anti CD3 monoclonal 60 Symphogen 60 glucokinase activator 60 L DOS# 60 huC# DM4 60 cancer immunotherapies 60 HGS# 60 MDV# 60 dacetuzumab 60 ibudilast 60 OncoVEX 60 Gemin X 60 Bendavia 60 AEG# 60 ALN VSP 60 EGEN 60 AP# [003] 60 GLPG# 60 bardoxolone 60 therapeutic antibodies 60 CCX# 60 Kahalalide F 60 Valortim 60 NKTR 60 MOZOBIL 60 volociximab 60 KRN# 60 dirucotide 60 Atiprimod 60 Androxal TM 60 #ME# 60 Phase IIb trial 60 SparVax ™ 60 midstage clinical trials 60 immune modulation 60 Memryte 60 PEG Interferon lambda 60 phase 2a 60 ImmunoVEX HSV2 60 Nanobody 60 bafetinib 60 vosaroxin 60 HIV integrase inhibitor 60 XL# [003] 60 Prodarsan R 60 small molecule inhibitors 60 siRNA therapeutics 60 HuMax CD# 60 Phase Ia 60 Trofex TM 60 Intarcia 60 MAXY G# 60 iSONEP 60 OHR/AVR# 60 Hedgehog antagonist 60 vascular disrupting agent 60 pharmacological chaperone 60 prostone 60 Zemiva TM 60 Pimavanserin 60 novel anticancer 60 Phase 2b trial 60 JAK3 60 bavituximab 60 Carfilzomib 60 deforolimus 60 Cintredekin Besudotox 60 HCV protease inhibitor 60 Synavive 60 GGF2 60 enzastaurin 60 Serdaxin 60 ATL# [001] 60 Azedra TM 60 TRO# 60 Hsp# inhibitor 60 Phenserine 60 GLP toxicology 60 Phase 1b clinical 60 mitogen activated ERK kinase 60 RhuDex ® 60 Kevetrin 59 Targeted Chemotherapy 59 CB2 selective receptor agonist 59 nalbuphine ER 59 tiapamil 59 preclinically 59 FOLOTYN ® 59 PS# [001] 59 GED aPC 59 ocrelizumab 59 GSK # 59 mertansine 59 telomerase inhibitor drug 59 Cloretazine ® 59 AEZS 59 entinostat 59 molecular imaging radiopharmaceutical 59 Solazed 59 CR# vcMMAE 59 BNC# 59 MEK inhibitor RDEA# 59 perifosine 59 ALN TTR 59 Curaxin 59 Bicifadine 59 trodusquemine 59 humanized monoclonal antibody 59 AVEO 59 rNAPc2 59 resolvin 59 alvespimycin 59 talactoferrin 59 trastuzumab DM1 T DM1 59 otelixizumab 59 Marqibo 59 elotuzumab 59 CUDC 59 NP2 Enkephalin 59 non nucleoside HCV 59 GALNS 59 PSMA ADC 59 TELINTRA 59 Anticalin 59 ChemoCentryx 59 Shigamabs ® 59 Aplidin 59 TKM Ebola 59 vidofludimus 59 Relivar 59 outlicensing 59 ONCONASE R 59 biomarker 59 voreloxin 59 Preclinical studies suggest 59 Aurora kinase inhibitor 59 omecamtiv mecarbil 59 HDAC inhibitor 59 Exelixis compounds 59 celgosivir 59 molecular chaperone 59 XL# XL# 59 registrational 59 Dacogen injection 59 Azedra ™ 59 vitro studies 59 ProSavin 59 EGS# 59 triphendiol 59 SMT C# 59 PF # [001] 59 Sphingomab 59 polymerase inhibitor 59 vivo validation 59 vitro experiments 59 PCK# 59 daclizumab 59 Sulonex 59 JAK inhibitors 59 Protexia R 59 NexACT 59 PREOS R 59 GRN# 59 novel histone deacetylase 59 novel peptide 59 QLT# 59 TBC# 59 MAXY alpha 59 Phase II 59 TACI Ig 59 Alpharadin 59 targeting CD# 59 PD LID 59 confirmatory Phase III 59 teplizumab 59 MBP# [001] 59 IMGN# 59 SparVax TM 59 eniluracil 59 EndoTAG TM -1 59 anticancer therapeutics 59 TOPIGEN 58 CA4P 58 PORxin TM 58 CombinatoRx 58 immunotherapeutic 58 XmAb# 58 Prednisporin TM 58 NEUGENE R 58 HCV nucleoside polymerase inhibitors 58 Zybrestat 58 ALTU 58 cGMP manufacture 58 metaglidasen 58 AACR NCI EORTC 58 Opexa 58 investigational compounds 58 tezampanel NGX# 58 RNAi therapeutic targeting 58 drug GAP #B# 58 antisense drugs 58 dacetuzumab SGN 58 depsipeptide 58 Hedgehog pathway inhibitor 58 PBT2 58 Solazed TM 58 Actilon 58 PEG PAL 58 HIV integrase inhibitors 58 Hybridon 58 Mipomersen 58 HuLuc# 58 proteasome inhibitor 58 antibody 58 Onalta ™ 58 kinase inhibitors 58 CGEN # 58 ADX# 58 investigational compound 58 HuMax EGFr 58 investigational hepatitis C 58 PROSTVAC TM 58 preclinical pharmacokinetic 58 Phase IIB 58 PORxin TM platforms 58 HGS ETR2 58 biologic 58 Virulizin 58 CYT# 58 MB# [004] 58 forodesine 58 HepeX B 58 epothilones 58 Hsp# inhibition 58 Phase #b/#a 58 NovaBay Aganocide compounds 58 investigational monoclonal antibody 58 romidepsin novel 58 candidate CRLX# 58 Anthim 58 Proxinium TM 58 telomerase therapeutic 58 carfilzomib 58 immunomodulatory 58 picoplatin 58 pivotal Phase III 58 pan HDAC inhibitor 58 Shigamabs R 58 humanized antibodies 58 HDL Mimetic Peptide 58 EOquin 58 CYT# potent vascular disrupting 58 disease modifying 58 NTDDS 58 Celator 58 IMA# 58 Chimigen TM 58 TRV# [001] 58 investigational 58 ELND-#/AZD-# 58 Tovaxin 58 Dynavax 58 THR beta agonist 58 bicifadine 58 Menerba 58 Jennerex 58 methylnaltrexone 58 pharmacokinetic studies 58 XOMA 58 Chrysalin 58 INxin TM 58 Virulizin R 58 NTx TM -# 58 INGN 58 torezolid phosphate 58 Anticalin R 58 Allovectin 7 58 huN# DM1 58 MAP# 58 PEGylated interferon 58 vilazodone 58 BiTE 58 ADME 58 Chemokine Therapeutics 58 Valortim ® 58 Aurora kinase inhibitors 58 Nasulin 58 SAR# [004] 58 VQD 58 Cytokinetics 58 adenoviral 58 ATL/TV# 58 CB2 selective 58 preclinical pharmacology 58 tremelimumab 58 pharmacodynamic 58 Nasdaq IDRA today 58 Chemokine 58 MAXY VII 58 novel therapeutic antibodies 58 ANG# 58 SARMs 57 Galenea 57 unpartnered 57 phase Ib 57 NovaBay 57 kinase inhibitor 57 elacytarabine 57 sodium thiosulfate STS 57 Surfaxin LS 57 Spiegelmer ® 57 ocular formulation 57 JAK2 inhibitors 57 siRNA therapeutic 57 histone deacetylase inhibitor 57 XL# XL# XL# XL# 57 Debio 57 L BLP# 57 ThGRF 57 Alocrest 57 ApoB SNALP 57 Apoptone 57 nucleoside tide 57 tafamidis 57 vascular disrupting agents 57 Trofex ™ 57 ICA # 57 Panzem R NCD 57 PRTX 57 Hematide TM 57 ProLindac 57 OMP #M# 57 transgenic mouse models 57 tezampanel 57 HE# [002] 57 lorvotuzumab mertansine 57 Amigal 57 CRD5 57 Cloretazine R 57 Alexza 57 lomitapide 57 DR Cysteamine 57 personalized immunotherapy 57 PDE# inhibitors 57 immunogenicity 57 tubulin inhibitor 57 PI3K delta 57 BiTE R 57 PNP inhibitor 57 antitumor 57 RAV# 57 SinuNase ™ 57 MCSP respectively 57 PsychoGenics 57 Trizytek 57 ridaforolimus 57 HCV protease inhibitors 57 axitinib 57 MGCD# [002] 57 NEUGENE antisense 57 Topical Interferon Alpha 2b 57 R#/MEM 57 ostarine 57 ganaxolone 57 ATL# [002] 57 SNALP technology 57 targeting PCSK9 57 cathepsin K inhibitor 57 IAP inhibitors 57 Investigational 57 FoldRx 57 IMC #B 57 EV# vaccine 57 Zalypsis 57 ALD# 57 AKT inhibitor 57 bremelanotide 57 LentiVector technology 57 generation URAT1 inhibitor 57 Posiphen 57 AeroLEF TM 57 selective androgen receptor modulators 57 INS# [001] 57 Phase #/#a 57 Lpathomab 57 mAb 57 small molecule tyrosine 57 Anticalin ® 57 oral bioavailability 57 ELND# 57 mGluR2 NAM 57 Tranzyme 57 Cloretazine R VNP#M 57 AMPK activators 57 epigenetic therapies 57 midstage studies 57 Versartis 57 investigational pan BCR 57 mGluR5 negative 57 EP #R 57 pharmacodynamic PD 57 R roscovitine 57 Annamycin 57 Tß4 57 nucleoside 57 Squalamine 57 MAb 57 QuatRx 57 tivozanib 57 Adnectin 57 neuroprotective 57 AAG geldanamycin analog 57 phase Ib clinical 57 IIa clinical 57 Asentar 57 AZD# 57 H#N# VLP vaccine 57 COTI 57 AERx iDMS 57 Neurogen 57 PHX# 57 Angiocept 57 investigational hepatitis B 57 NNR Therapeutics 57 allosteric modulation 57 AZX# 57 AMPAKINE 57 HCV polymerase inhibitors 57 BioFocus DPI 57 DPX Survivac 57 CBLC# 57 leading oral taxane 57 systemic RNAi 57 Phase Ib II 57 maturation inhibitor 57 Allovectin 7 R 57 GSK# [002] 57 CINOD 57 ALN HTT 57 ReN# 57 BioVant 57 humanized monoclonal antibodies 57 anti CD3 57 favorable pharmacokinetic profile 57 TKM PLK1 57 liposomal formulation 57 HEPLISAV ™ 57 reslizumab 57 HCD# [002] 57 Stimuvax R 57 AMPAKINE R 57 alagebrium 57 Myrexis 57 Cutanea 57 Nanobodies 57 oncology indications 57 TÎ ² 4 57 OncoVex 57 tanespimycin 57 AEOL # 57 YONDELIS 57 oritavancin 57 squalamine 57 clinical pharmacology studies 57 VA# [002] 57 Tyrima 57 tolevamer 57 solithromycin 57 siRNA 57 PrevOnco 57 anticancer compounds 57 multicenter Phase II 57 Tarvacin 57 bevirimat 57 Urocortin 2 57 DB# [003] 57 IAP inhibitor 57 ulimorelin 57 Nanobodies ® 57 Safinamide 57 Viprinex 57 velafermin 57 Cogane 57 Protectan CBLB# 57 immunotherapeutics 57 neuroprotective properties 57 cancer therapeutics 57 Anaphore 57 Ceregene 57 Corlux 57 immunological diseases 57 bardoxolone methyl 57 TLR antagonists 57 PEGPH# 57 indibulin 57 Myocet 57 HuMax CD4 57 Ophthotech 57 aldehyde dehydrogenase ALDH2 deficiency 57 Fentanyl TAIFUN R 56 orally dosed 56 EVIZON TM squalamine lactate 56 OxBC 56 Expression Genetics 56 LymphoStat B 56 Idenix 56 YONDELIS R 56 Plicera 56 Harbor BioSciences 56 AzaSite Plus 56 oligonucleotide therapeutics 56 Aganocide ® 56 crofelemer 56 protein kinase inhibitor 56 novel RNAi therapeutics 56 adrenergic regulation 56 Vitaxin 56 XmAb 56 PDX pralatrexate 56 REP# 56 elesclomol 56 belinostat 56 antibody MAb 56 fosbretabulin 56 GDIR 56 Valortim R 56 Alzhemed TM 56 ARIUS 56 Achillion 56 tosedostat 56 aurora kinase 56 multiple ascending dose 56 non alcoholic steatohepatitis 56 GRNVAC1 56 fipamezole 56 Belinostat 56 anticoagulant reversing agent 56 antisense inhibitors 56 Ceflatonin R 56 biologic therapeutics 56 Omacetaxine 56 Anacor 56 SAR# [002] 56 PANVAC VF 56 SinuNase TM 56 P#X# antagonist 56 ESBA# 56 P#X# 56 EndoTAG TM 56 PRX# 56 allosteric modulator 56 therapeutic proteins 56 oral antiviral 56 IRX 2 56 Santaris 56 antiviral therapeutics 56 biased ligand 56 Janus Kinase 56 Resolvyx 56 BrachySil TM 56 ASA# 56 LungExpress Dx TM 56 Personalized Immunotherapy 56 BioFocus 56 GeneICE 56 CCR2 56 neuropathic pain 56 pafuramidine 56 ENMD 56 hGH CTP 56 LY# [003] 56 IIa trial 56 intranasal formulation 56 Mpex 56 glufosfamide 56 Insegia 56 tranilast 56 Ligand 56 nanopharmaceutical 56 nucleotide analog 56 vivo pharmacology 56 #D#C# 56 Lixivaptan 56 HDAC Inhibitor 56 Proellex TM 56 HepDirect 56 AVE# 56 Regado 56 confirmatory Phase 3 56 siRNAs targeting 56 Hedgehog agonist 56 arimoclomol 56 VitiGam 56 rindopepimut 56 HSP# inhibitor 56 IL# PE#QQR 56 AMPAKINE CX# 56 tasimelteon 56 Targacept 56 sulodexide 56 RNA interference RNAi therapeutics 56 Aganocide 56 nitric oxide donating prostaglandin 56 ARRY 56 ongoing Phase 1b 56 Tesetaxel 56 pharmacodynamic properties 56 CD# monoclonal antibody 56 biotherapeutics 56 visilizumab 56 Zerenex 56 diabetes irritable bowel 56 RNA antagonist 56 Pharmasset 56 Ostarine 56 ProMune 56 PEP# [003] 56 Miraxion Amarin lead 56 cyclophilin inhibitors 56 PRLX # 56 Aurexis 56 defensin mimetic antibiotic 56 Cetrorelix 56 Cannabinor 56 OvaRex ® MAb 56 MT# MEDI 56 molecular biomarkers 56 PREOS 56 Curis 56 Phenoptin 56 Marqibo TM 56 Immunotherapeutic 56 Neuradiab 56 elagolix 56 kinase profiling 56 Prednisporin 56 oncolytic 56 Lpath 56 TLR8 agonist 56 Ocrelizumab 56 Phase 1a 56 Nuvion 56 phosphatidylserine PS targeting 56 Pervasis 56 polyclonal antibody 56 Anavex #-# 56 pivotal Phase 56 polymerase inhibitors 56 LymphoStat B TM 56 Romidepsin 56 immunoregulation 56 CG# [003] 56 Oral NKTR 56 Interferon alpha 56 biobetter 56 Hsp# inhibitors 56 ImmunoGen 56 lintuzumab 56 CoFactor 56 PTH analogue 56 HCV antiviral 56 XOMA 3AB 56 prokinetic agent 56 MT#/MEDI-# 56 romazarit 56 systemic RNAi therapeutic 56 CD# antibody [001] 56 Etubics 56 Elusys 56 orally administered 56 radiation sensitizer 56 Phase 1b clinical trials 56 AEGR 56 punctal plug 56 LEP ETU 56 Veronate 56 betrixaban 56 imetelstat 56 incyclinide 56 Sulonex TM 56 radiotherapeutic 56 Avicena 56 Xanafide 56 TLK# 56 humanized antibody 56 Fc fusion protein 56 ongoing Phase IIIb 56 Hyphanox 56 TELCYTA 56 Adenosine Therapeutics 56 Hedgehog signaling pathway 56 CCR5 antagonist 56 ATHX 56 clevudine 56 pomalidomide 56 XL# anticancer compounds 56 liprotamase 56 Valdoxan 56 Poly ICR 56 SRT# [003] 56 budiodarone 56 dimebon 56 anti angiogenic 56 hypoxia activated prodrug 56 ataluren 56 Maxy G# 56 lintuzumab SGN 56 Vaccinex 56 drug conjugate 56 HuCAL antibodies 56 Lisofylline LSF 56 PI3K/mTOR 56 ImQuest 55 phase IIb study 55 systemically administered 55 retapamulin 55 novel anti infective 55 NEUGENE 55 immune modulating 55 davunetide intranasal AL 55 PF # [002] 55 masitinib 55 vaccine GRNVAC1 55 adipiplon 55 Aurora kinase 55 recombinant biopharmaceutical 55 Fodosine 55 Semafore 55 torsemide ER 55 antitumoral 55 KSP inhibitor 55 Tekmira 55 vitro 55 Monoclonal Antibody 55 novel therapeutics 55 carcinogenicity study 55 immatics 55 Hedgehog pathway 55 monoclonal 55 Tranzyme Pharma 55 Perifosine 55 anti fibrotic 55 Ramoplanin 55 antisense inhibitor 55 darinaparsin ZIO 55 KL4 surfactant 55 immunotherapeutic vaccine 55 Nautilus Biotech 55 PEGylated 55 neratinib 55 Trophos 55 Lycera 55 virus HCV protease inhibitor 55 ELACYT 55 potent antitumor activity 55 enGene 55 Daclizumab 55 Stapled Peptide 55 lumiliximab 55 novel antibody therapeutics 55 VLP vaccine 55 Kosan dependence 55 MORAb 55 pivotal bioequivalence 55 RenaZorb TM 55 Tβ4 55 renin inhibitors 55 Ambrx 55 TLR9 agonist 55 TaiGen 55 Pharmos pipeline 55 Innovive 55 ZFP Therapeutic TM 55 DNA RNA Medicines 55 Addex 55 Traficet EN 55 ruxolitinib 55 Dr. Marlies Sproll 55 RNAi 55 trastuzumab DM1 55 DAVANAT 55 SIRT1 activators 55 Fibrillex TM 55 CK # novel 55 CRF1 receptor antagonist 55 potently inhibit 55 Calistoga Pharmaceuticals 55 novel VDA molecule 55 therapeutic 55 Radezolid 55 BZL# 55 urocortin 2 55 GRNCM1 55 Riquent 55 gallium containing 55 Inotek 55 exon skipping 55 promising anticancer 55 SUVN 55 including eniluracil ADH 55 Aganocide R 55 Xcytrin R 55 renin inhibitor 55 Dr. Aiping Young 55 Locteron 55 PNT# 55 CK # 55 almorexant 55 BAY #-# 55 Phase #b/#a clinical 55 gene expression profiling 55 omacetaxine 55 Cellzome 55 TKB# 55 Virulizin ® 55 TG# [001] 55 Thiovir 55 rALLy trial 55 custirsen 55 VentiRx 55 HCV polymerase 55 medicinal chemistry 55 Proteolix 55 Cotara R 55 Exherin 55 oral PTH 55 Zenvia Phase III 55 rBChE